Vaxart Inc. (VXRT): Price and Financial Metrics
VXRT Price/Volume Stats
| Current price | $0.41 | 52-week high | $1.07 |
| Prev. close | $0.40 | 52-week low | $0.29 |
| Day low | $0.40 | Volume | 769,490 |
| Day high | $0.41 | Avg. volume | 1,883,771 |
| 50-day MA | $0.40 | Dividend yield | N/A |
| 200-day MA | $0.64 | Market Cap | 92.53M |
VXRT Stock Price Chart Interactive Chart >
Vaxart Inc. (VXRT) Company Bio
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.
VXRT Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VXRT Price Returns
| 1-mo | 5.48% |
| 3-mo | -12.73% |
| 6-mo | -34.72% |
| 1-year | -48.69% |
| 3-year | -89.04% |
| 5-year | -83.06% |
| YTD | -38.08% |
| 2024 | 15.59% |
| 2023 | -40.39% |
| 2022 | -84.67% |
| 2021 | 9.81% |
| 2020 | 1,529.10% |